Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
LongBio Pharma (Suzhou) and Dajin Heavy Industry kick off bookbuilding for Hong Kong IPO
Hong Kong welcomes two Chinese firms to kick off their bookbuilding for listing in Hong Kong on Thursday. SCROLL TO CONTINUE WITH CONTENT LongBio Pharma (Suzhou), a clinical-stage Chinese biopharmaceutical startup, plans to offer 14.19 million H…
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
Press release – No. 11 / 2026 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, May 27, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the…
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater presentation and poster…
Exclusive: Solstice raises $21M for pharma marketing
Axios Pro Exclusive Content 2 hours ago…
Sanofi is building its own AI ecosystem to give the French pharma giant an edge
In the early days of the generative artificial intelligence boom, Sanofi's chief digital officer, Emmanuel Frenehard, wasn't particularly impressed with the AI tools that were being pitched. The French pharmaceutical giant eschewed licensing an…
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
HERZLIYA, Israel and CALGARY, AB, May 27, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan'), a pharmaceutical technology company focusing on developing innovative drug delivery platform…
Indian pharma set to gain from CEPA with Oman
Ahead of the India–Oman Comprehensive Economic Partnership Agreement implementation, pharma exporters body Pharmexcil has highlighted the opportunities that await Indian pharmaceutical, AYUSH and wellness sectors. “One of the…
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
The VanEck Pharmaceutical ETF (PPH 0.83%) provides targeted exposure to drug manufacturers, while the iShares Global Healthcare ETF (IXJ 0.86%) offers a broader reach across the international medical industry including biotechnology and equipment.
Bollywood Actor Salim Diwan Takes Over Krux Pharma Pvt. Ltd. in 50 Million USD Deal for Strategic Global Business Expansion
Bollywood actor and entrepreneur Salim Diwan has once again made headlines—this time not for a film, but for a significant business milestone. Diwan has acquired pharmaceutical company Krux Pharma Pvt. Ltd. in a deal valued at 50 million…
Have Hope: Psychiatry Officially Embraces the Future
In a hallowed tradition, psychiatrists from across the country gathered together to meet and discuss our field as we have done most years since 1844. What was different this year at the American Psychiatric Association meeting was that the…
How to fix AI's branding problem, according to top marketers
How do you solve a branding problem like AI? Marketers have some ideas, like borrowing from P&G's marketing playbook or creating a think tank. It's no secret that AI is getting a bad rap. Boos at college graduation speeches. AI-related layoffs.
Marketers Keep Conflating Gen X With Boomers-And It's Costing Them
The future of brands gets decided here. Join the industry's top marketers at Brandweek for the ideas, insights, and connections shaping what's next. Get your ticket. Gen X is known as “the forgotten generation,” and that appears to…
Three Companies Seeking to Raise Up to $1B, Joining Hong Kong Listing Wave
The largest of the three offerings is likely to be by Dajin Heavy Industry, which aims to raise up to 5.77 billion Hong Kong dollars, equivalent to US$736.4 million, through the sale of nearly 87.0 million shares at a maximum price of HK$66.40…
The Next AI Opportunity Is The Research Office
Mayank Kejriwal - CEO and Co-Founder of GRAIL. When business leaders talk about AI, the conversation usually starts with customer service, software development or marketing. I believe one of the biggest overlooked opportunities is the…
China's biotech boom drives surge in home-grown innovative drug approvals
Home-grown innovative drugs make up most of the medicines China's drug regulator has approved for sale so far this year, underscoring the country's biotech boom. Of the 19 innovative drugs cleared by the National Medical Products Administration…
Receive a Daily briefing on Pharma Industry News
Get Started